HINDHealthcareSmall-Cap
ReShape Lifesciences Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for ReShape Lifesciences Inc. (HIND), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are HIND insiders buying or selling?
ReShape Lifesciences Inc. insiders reported 20 open-market buys ($6.8M) and 33 sells ($16.1M) across 53 Form 4 filings — a net selling position of $9.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Aug 13, 2024)
Total Form 4 filings
53
SEC EDGAR
Insider filers
15
Insider buys (20)
$6.8M
Insider sells (33)
$16.1M
Insider sentiment
Net sellingNet insider flow of $9.4M in net selling.
Recent HIND insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 13, 2024 | Thomas Stankovich | Chief Financial Officer | Sale | 172 | $0.23 | $38.78 |
| Nov 8, 2023 | Thomas Stankovich | Chief Financial Officer | Sale | 435 | $0.89 | $386.48 |
| Jul 19, 2023 | Thomas Stankovich | Chief Financial Officer | Sale | 106 | $1.47 | $155.82 |
| Jul 6, 2023 | Thomas Stankovich | Chief Financial Officer | Purchase | 17.4K | $1.50 | $26.2K |
| Mar 7, 2023 | Thomas Stankovich | Chief Financial Officer | Sale | 418 | $8.87 | $3.7K |
| Dec 20, 2022 | Thomas Stankovich | Chief Financial Officer | Sale | 372.1K | $0.17 | $62.9K |
| Nov 10, 2022 | Thomas Stankovich | Chief Financial Officer | Sale | 8.4K | $0.27 | $2.3K |
| Oct 6, 2022 | Thomas Stankovich | CFO | Sale | 8.3K | $0.28 | $2.3K |
| Sep 12, 2022 | Thomas Stankovich | Chief Financial Officer | Sale | 4.8K | $0.39 | $1.9K |
| Aug 11, 2022 | Thomas Stankovich | Chief Financial Officer | Sale | 4.7K | $0.47 | $2.2K |
| Aug 11, 2022 | Barton P. Bandy | President and CEO | Sale | 11.7K | $0.47 | $5.5K |
| Jul 6, 2022 | Thomas Stankovich | Chief Financial Officer | Sale | 4.6K | $0.55 | $2.5K |
| Jul 6, 2022 | Barton P. Bandy | President and CEO | Sale | 11.4K | $0.55 | $6.3K |
| Jun 6, 2022 | Barton P. Bandy | President and CEO | Sale | 11.3K | $0.95 | $10.8K |
| Jun 6, 2022 | Thomas Stankovich | Chief Financial Officer | Sale | 4.5K | $0.96 | $4.3K |
| Jun 1, 2022 | Thomas Stankovich | Chief Financial Officer | Purchase | 20.0K | $0.92 | $18.4K |
| May 12, 2022 | Barton P. Bandy | President and CEO | Sale | 11.4K | $0.77 | $8.8K |
| Apr 8, 2022 | Thomas Stankovich | Chief Financial Officer | Sale | 5.0K | $1.13 | $5.7K |
| Apr 8, 2022 | Barton P. Bandy | President and CEO | Sale | 11.1K | $1.13 | $12.5K |
| Mar 2, 2022 | Thomas Stankovich | CFO | Sale | 3.7K | $1.06 | $3.9K |
| Mar 2, 2022 | Barton P. Bandy | President and CEO | Sale | 6.5K | $1.06 | $6.9K |
| Feb 2, 2022 | Barton P. Bandy | President and CEO | Sale | 8.3K | $1.22 | $10.2K |
| Feb 2, 2022 | Thomas Stankovich | Chief Financial Officer | Sale | 3.7K | $1.22 | $4.5K |
| Jan 28, 2022 | Barton P. Bandy | President and CEO | Sale | 7.2K | $1.79 | $12.8K |
| Jan 28, 2022 | Thomas Stankovich | Chief Financial Officer | Sale | 3.2K | $1.78 | $5.6K |
Showing the 25 most recent of 53 Form 4 filings for ReShape Lifesciences Inc..
Most active HIND insiders
- Thomas Stankovich24 filings
- Barton P. Bandy12 filings
- DOMAIN PARTERS VII L P2 filings
- INTERWEST PARTNERS X LP2 filings
- Kim P. Kamdar2 filings
Ask anything about HIND insider activity
Use Trabud's AI agent to query ReShape Lifesciences Inc.'s Form 4 history in plain English — "Show me HIND CEO purchases this year" or compare it against any other ticker.
Open the AI agentHIND insider trading FAQ
Are ReShape Lifesciences Inc. insiders buying or selling?
Across 53 SEC Form 4 filings, ReShape Lifesciences Inc. (HIND) insiders reported 20 open-market purchases totaling $6.8M and 33 sales totaling $16.1M. That is a net selling position of $9.4M.
How many insiders trade HIND stock?
15 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for ReShape Lifesciences Inc.. The most recent filing was accepted on Aug 13, 2024.
Where does Trabud get HIND insider trading data?
All HIND insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.